TBIQYR5122-Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Research Report 2019

  • TBI226018
  • February 11, 2019
  • Global
  • 103 pages
  • QY Market Research
                                          

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD. North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%. The global Liposome Drug Delivery (Liposomes Drug Delivery) market is valued at 2600 million US$ in 2018 is expected to reach 6040 million US$ by the end of 2025, growing at a CAGR of 12.8% during 2019-2025. This report focuses on Liposome Drug Delivery (Liposomes Drug Delivery) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liposome Drug Delivery (Liposomes Drug Delivery) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Gilead Sciences Pacira Sun Pharmaceutical Johnson & Johnson Luye Pharma Sigma-Tau Group Ipsen (Onivyde) CSPC Teva Pharmaceutical Novartis Fudan-Zhangjiang Segment by Regions North America Europe China Japan Segment by Type Liposomal Doxorubicin Liposomal Amphoteracin B Liposomal Paclitaxel Others Segment by Application Fungal Infection Therapy Cancer & Tumor Therapy Others

Table of Contents

Executive Summary
1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Overview
    1.1 Product Overview and Scope of Liposome Drug Delivery (Liposomes Drug Delivery)
    1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Type
        1.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Liposomal Doxorubicin
        1.2.3 Liposomal Amphoteracin B
        1.2.4 Liposomal Paclitaxel
        1.2.5 Others
    1.3 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Application
        1.3.1 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Comparison by Application (2014-2025)
        1.3.2 Fungal Infection Therapy
        1.3.3 Cancer & Tumor Therapy
        1.3.4 Others
    1.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market by Region
        1.3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size Region
        1.3.2 North America Status and Prospect (2014-2025)
        1.3.3 Europe Status and Prospect (2014-2025)
        1.3.4 China Status and Prospect (2014-2025)
        1.3.5 Japan Status and Prospect (2014-2025)
        1.3.6 Southeast Asia Status and Prospect (2014-2025)
        1.3.7 India Status and Prospect (2014-2025)
    1.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size
        1.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue (2014-2025)
        1.4.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production (2014-2025)

2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Competition by Manufacturers
    2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Manufacturers (2014-2019)
    2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Share by Manufacturers (2014-2019)
    2.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites, Area Served, Product Types
    2.5 Liposome Drug Delivery (Liposomes Drug Delivery) Market Competitive Situation and Trends
        2.5.1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Concentration Rate
        2.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Share ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form